Can GLP-1 Medications help Lymphedema?

GLP-1 Medications and Lymphedema: What the Research Says (and How to Get the Best Results)

Could GLP-1 Medications Help Lymphedema?

GLP-1 receptor agonists (such as semaglutide, liraglutide, and tirzepatide) are widely known for their role in weight loss and blood sugar control.

But a new and important question is emerging:

Could these medications also improve lymphedema—or even reduce the risk of developing it?

Early research suggests the answer may be yes—but with important caveats.

What Are GLP-1 Medications? (And Why They Matter Here)

GLP-1 receptor agonists are part of a class of medications called incretin mimetics. They:

• Increase insulin secretion (when needed)
• Reduce appetite and increase satiety (feeling of fullness after a meal)
• Slow stomach emptying (so you feel full longer)
• Promote significant weight loss
• May reduce inflammation and improve metabolic health (Zupec, 2025)

These effects matter because weight, inflammation, and insulin resistance are all linked to lymphedema risk and severity.

What the Research Shows: GLP-1s and Lymphedema Risk

1. Large Study: Reduced Risk of Developing Lymphedema

A 2024 study of 3,830 breast cancer patients undergoing axillary lymph node dissection (ALND) found (Brown, 2024):

• Lymphedema incidence:
  • 6.6% in GLP-1 users
  • 28.5% in non-users
• Patients on GLP-1s were:
  • 86% less likely to develop lymphedema (OR 0.14)

Even in patients without diabetes, the protective effect remained:

• 84% lower risk (OR 0.16)

Why this matters:

This is one of the first large studies suggesting that GLP-1 medications may play a preventive role, in helping to reduce the risk of developing lymphedema after cancer treatment, not just a weight-loss role.

2. Case Study: Improvement in Existing Lymphedema

A 2024 case report documented a woman with breast cancer–related lymphedema who (Crowley, 2024):

• Lost 24% of body weight on a GLP-1 medication (semaglutide)
• Reduced limb volume difference:
  • 10.3% → 3.4%
• No longer required compression garments
• Showed restored lymphatic pumping on imaging

Why this matters:

This suggests GLP-1s may not only reduce risk—but also improve established lymphedema in some cases.

How GLP-1s May Affect the Lymphatic System

While research is still emerging, several mechanisms are likely involved:

1. Weight Reduction

• Higher BMI is a known risk factor for lymphedema
• Even modest increases in weight can worsen symptoms
• GLP-1s can produce 15–25% weight loss in some patients

2. Improved Insulin Sensitivity

• Insulin resistance is increasingly linked to impaired lymphatic function (Doruk Analan, 2022)

3. Reduced Inflammation

• Lymphedema is driven by chronic inflammation and fibrosis (Ly, 2017)
• GLP-1s may have anti-inflammatory effects beyond weight loss

4. Potential Direct Effects on Lymphatic Function

In a case report, GLP-1 therapy was associated with (Crawley, 2024):

• Improved lymphatic pumping on imaging, although this finding has not yet been confirmed in larger studies.

Important Reality Check: GLP-1s Are Not a “Lymphedema Treatment” (Yet)

It’s important to be clear:

• There is no approved medication for lymphedema (yet)
• Current evidence includes:
  • One large observational study
  • One case report
• More research is needed on the effectiveness of GLP-1s for lymphedema

That said…

These findings are clinically meaningful and highly relevant, especially for people who:

• Have had lymph node removal surgery or injury to their lymphatic system
• Are at risk of lymphedema
• Are experiencing weight gain after lymph-impacting cancer treatment

Where Nutrition Makes or Breaks Your Results

This is the piece that’s often missing.

GLP-1 medications can help—but how you eat while on them directly affects:

• Muscle mass retention
• Metabolic health
• Inflammation
• Long-term weight maintenance
• And potentially… lymphedema outcomes

Key insights from clinical nutrition guidance:

From the Zupec review and clinical practice:

• GI side effects are common (nausea, vomiting, diarrhea)
• Eating patterns matter:
  • Smaller meals
  • Lower-fat foods
  • Adequate protein intake
• Patients need ongoing support and monitoring for best outcomes (Zupec, 2025)

GLP-1 + Lymphedema: What Actually Works Best

Based on both research and clinical experience, the best outcomes happen when you combine:

1. Medical therapy (when appropriate)

When appropriately prescribed and monitored, these medications may:

• Support weight loss
• Improve metabolic health
• Reduce chronic disease health risk
• Have a positive impact on lymphedema

2. Lymphedema management with a certified lymphedema therapist

Caring for lymphedema is more than just taking a GLP-1. With or without the medication, you will still need to work with your certified lymphedema therapist and perform your daily self-care

• Compression
• Movement and exercise
• Manual lymphatic therapies
• Skin care

3. Targeted nutrition strategy

This is where most people struggle—and where results can plateau or reverse. Both GLP-1s and lymphedema have important nutrition strategies to help improve outcomes. The same goes with both apply.

Why Working with a Dietitian Who Understands Both Matters

Not all nutrition support is the same.

And not all providers understand:

• The metabolic effects of GLP-1 medications
• The pathophysiology of lymphedema and the important nutrition implications

To get the best results, you need both.

A tailored plan can help you:

• Preserve muscle while losing weight
• Reduce inflammation
• Support lymphatic function
• Manage side effects
• Avoid rebound weight gain
• Improve long-term outcomes

This is especially important if you have:

• Cancer-related lymphedema
• Lipedema
• Insulin resistance
• Weight changes after treatment

Who Might Benefit Most from GLP-1s in This Context?

Based on current evidence, potential candidates include:

• Breast cancer survivors post–lymph node removal
• Individuals with:
  • Elevated BMI
  • Insulin resistance
  • Weight gain after cancer treatment (any type of cancer treatment that involved lymph node removal and/or radiation)
• Those struggling with:
  • Lymphedema progression
  • Difficulty losing weight despite effort

Key Takeaways on GLP-1s and Lymphedema:

• • • GLP-1 medications may:
      • Reduce the risk of developing lymphedema
      • Improve existing lymphedema 
    • Effects likely go beyond weight loss alone
    • Nutrition plays a critical role in outcomes
    • The best results come from integrated care
    • More research on the use of GLP-1s for lymphedema risk reduction and management would be most welcome

Book a free 15 minute consultation with a registered dietitian that understands both GLP-1s and lymphedema to discuss your situation and whether a personalized nutrition plan could help.

References for GLP-1 Use for Lymphedema

Brown S, Tet al. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may reduce the risk of developing cancer-related lymphedema following axillary lymph node dissection (ALND). Front Pharmacol 2024;15:1457363

Crowley F, Brown S, Gallagher EJ, Dayan JH. GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report. Front Oncol. 2024 Apr 18;14:1392375.

Doruk Analan P, Kaya E. Is There a Relationship Between Insulin Resistance and Breast Cancer-Related Lymphedema? A Preliminary Study. Lymphat Res Biol 2022;20(1):76–81

Ly CL, Kataru RP, Mehrara BJ. Inflammatory Manifestations of Lymphedema. Int J Mol Sci. 2017;18(1):171.

Zupec J, Munger R, Scaletta A, Quinn DH. Use of glucagon-like peptide-1 receptor agonists and incretin mimetics for type 2 diabetes and obesity: A narrative review. Nutr Clin Pract. 2025 Apr;40(2):327-349.